|
| |
DigeneA leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests focused on women's cancers and infectious diseases. The company's flagship product, The Digene® HPV Test* (DNAwithPap® Test), is the only FDA–approved test for the human papillomavirus (HPV), the primary cause of cervical cancer. Rapidly emerging as a standard of practice in cervical cancer screening, the HPV test aids healthcare professionals in identifying women who are most at risk of having or developing cervical cancer, which today is the world's second–most–common type of cancer affecting women.
Digene's product portfolio also includes DNA tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea, as well as tests for blood viruses. Through its own staff or affiliated distributors, Digene markets its tests in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE.
| Contact Details: |
| 1201 Clopper Road |
| Gaithersburg |
| MD |
| 20878 |
| United States of America |
| Tel: | 301 944 7000 |
| Fax: | 240.632.7121 |
| Email: | inforeq@digene.com |
| WWW: | www.digene.com/
|
|
Loading...
|
Recent Publications by Digene: |  |
Effect of sample aliquot size on the limit of detection and reproducibility of clinical assays.
BACKGROUND: Nucleic acid amplification technologies significantly improved... | 19th December, 2007
| Digene Corporation, Research and Development, Gaithersburg, MD 20878, USA.
| Clin Chem. 2007 Nov;53(11):1962-5. Epub 2007 Aug 30.
DOI Direct Link |
Homogeneous detection of nucleic acids using self-quenched polymerase chain reaction primers labeled with a single fluorophore (LUX primers).
Multiplex quantitative polymerase chain reaction (PCR) based on novel... | 12th October, 2007
| Research and Development, Digene Corporation, Gaithersburg, MD, USA.
| Methods Mol Biol. 2006;335:95-114.
DOI Direct Link |
HPV technologies advancing public health: discussion of recent evidence.
Effective primary and secondary cancer prevention programmes are key to... | 20th July, 2007
| International Public Affairs, Digene, Geneva, Switzerland.
| Coll Antropol. 2007 Apr;31 Suppl 2:55-60.
|
Cervical HPV DNA Detection as a Predictor of a Recurrent SIL Diagnosis Among Untreated Women.
OBJECTIVES: This study was conducted to test whether patient history of... | 20th October, 2006
| *Division of Cancer Epidemiology and Genetics, National Cancer Institute,
| J Low Genit Tract Dis. 2001 Jul;5(3):138-143.
|
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
We examined whether higher human papillomavirus type 16 (HPV16) viral load... | 15th December, 2005
| Digene Corporation, 1201 Clopper Road, Gaithersburg, MD 20878, USA.
| Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1311-4.
DOI Direct Link |
→View more Digene research publications. |
Press Releases on Digene:
|
 |
| Gen-Probe Reports Financial Results for Third Quarter 2009 |
29th October, 2009 |
Gen-Probe Incorporated |
-- $10.0 million of collaborative research revenue ($0.12 of EPS), which
was recorded from the Company's commercial partner, Novartis
Diagnostics, in the third quarter of
|
| Reportlinker Adds In Vitro Diagnostics US Market Report |
1st October, 2009 |
Reportlinker |
NEW YORK, Oct. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
In Vitro Diagnostics US Market
http://www.reportlinker.com/p0109780/In
|
| Reportlinker Adds Who's Doing What in Molecular Diagnostics? - Kalorama / Emmes Survey of US Laboratories Report |
24th September, 2009 |
Reportlinker |
-- Communicable Diseases - CMV (Cytomegalovirus), EBV (Epstein-Barr Virus),
Group B Strep, Enterovirus
What Labs Do Now, What They are Planning in the Future
There has been much analysis
|
| Reportlinker Adds What is Working in IVD: Successful Commercialization of New Products and Technologies Report |
24th September, 2009 |
Reportlinker |
-- Market Forces Management, strategies for working with: Investors, the
Scientific Community, Consumers and more
It is estimated that there are several hundred new tests and test
|
| Gen-Probe Reports Financial Results for First Quarter 2009 |
30th April, 2009 |
Gen-Probe Incorporated |
Three Months Ended March 31, Change
2009 2008 Reported Constant
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 625 times since April 2007, the link to the organisation's website has been followed 107 times Recent Search Terms used to find this page: history digene | HPV Test UAE | diagene gaithersburg md | f | HPV probe | digene patents | digene hpv test | digene | digene financial | digene locations | . Search for more companies in Gaithersburg Search for more companies in MD This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Digene |
